Open official notice

Tandem Mobi Insulin Pump, Models: 1004004, 1010750, 1012676, 1012719, 1013655, 1013656, 1013501, 1013700, 1014081, 1014801, 1014811

Official notice

11 Nov 2026

Last checked

17 Nov 2026

RecallScope risk estimate:CriticalFDA

An official FDA notice concerns Tandem Mobi Insulin Pump, Models: 1004004, 1010750, 1012676, 1012719, 1013655, 1013656, 1013501, 1013700, 1014081, 1014801, 1014811. Tandem Diabetes Care, Inc. ( Tandem ) has identified that certain Tandem Mobi insulin pumps may generate false-positive occlusion alarms when no actual insulin flow obstruction is present. Investigation determined that increased friction within the drive module can reduce available motor power and, under certain conditions, cause motor speed to fall below the occlusion detection threshold. As a result, the pump may incorrectly detect an occlusion condition and suspend insulin delivery. When an occlusion alarm occurs, insulin delivery remains suspended until the user acknowledges the alarm and resumes therapy. Repeated false-positive occlusion alarms, if not addressed promptly, may result in interruptions of insulin delivery that can increase the risk of elevated blood glucose levels. In severe cases, hyperglycemia may require medical intervention or hospitalization. Published 2026-11-11.

What to do now

Stop using the affected device and follow the corrective action in the official FDA notice. Contact your healthcare provider or the manufacturer for next steps.

Units affected

80,938

Recall number

Z-0316-2027

Official notice

2026-11-11

The hazard

Tandem Diabetes Care, Inc. ( Tandem ) has identified that certain Tandem Mobi insulin pumps may generate false-positive occlusion alarms when no actual insulin flow obstruction is present. Investigation determined that increased friction within the drive module can reduce available motor power and, under certain conditions, cause motor speed to fall below the occlusion detection threshold. As a result, the pump may incorrectly detect an occlusion condition and suspend insulin delivery. When an occlusion alarm occurs, insulin delivery remains suspended until the user acknowledges the alarm and resumes therapy. Repeated false-positive occlusion alarms, if not addressed promptly, may result in interruptions of insulin delivery that can increase the risk of elevated blood glucose levels. In severe cases, hyperglycemia may require medical intervention or hospitalization.

How to check if you’re affected

Compare the product name and identifiers below with the item you own. Check the official notice for the affected products and next steps.

Other

UDI-DI 00389152075013

Event Ids

99851

Recall Numbers

Z-0316-2027

Checked manually this time?

Follow brands and keywords in the app to receive alerts for matching official notices.

Turn on recall alerts

Affected products

Product 1

Tandem Mobi Insulin Pump, Models: 1004004, 1010750, 1012676, 1012719, 1013655, 1013656, 1013501, 1013700, 1014081, 1014801, 1014811, 1014813, 1014936, 1016911, 1016912, 1016913, 1016914, 1018075, 1018077, 1018078

Units affected

80,938

Hazard

Tandem Diabetes Care, Inc. ( Tandem ) has identified that certain Tandem Mobi insulin pumps may generate false-positive occlusion alarms when no actual insulin flow obstruction is present. Investigation determined that increased friction within the drive module can reduce available motor power and, under certain conditions, cause motor speed to fall below the occlusion detection threshold. As a result, the pump may incorrectly detect an occlusion condition and suspend insulin delivery. When an occlusion alarm occurs, insulin delivery remains suspended until the user acknowledges the alarm and resumes therapy. Repeated false-positive occlusion alarms, if not addressed promptly, may result in interruptions of insulin delivery that can increase the risk of elevated blood glucose levels. In severe cases, hyperglycemia may require medical intervention or hospitalization.

Where it was sold

Retailer information is not currently available in RecallScope. Check the official notice for distribution details.

Location 1

US · United States

Affected area 1

US · United States

Affected area 2

CA · Canada

Company & contacts

Manufacturer

Tandem Diabetes Care, Inc.

Phone

Not provided

Brand: Tandem Diabetes Care. Contact: Tandem Diabetes Care, Inc..

Source & status

Source

Tier

official

Category

Tech & Electronics

Official classification

Class I

Recall details

Recall number

Z-0316-2027

Event ID

99851

Units affected

80,938

Status

active

Source tier

official

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Weekly recall digest

Get next week’s recalls before you need them.

One email every Monday with official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest arrives once a week. For matching recall alerts after notices are processed, get the app.

This recall was published 11 Nov 2026. The next one won’t wait for you to search.

RecallScope checks listed publishers for the brands and VINs you follow, and can alert you when a matching notice is processed.

apple-buttongoogle-button